APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alternative to Antibiotics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Alternative to Antibiotics Industry Research Report 2026

1 January 2026144 pages

Choose your research edition.

Industry ResearchAlternative to Antibiotics Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Alternative to Antibiotics Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Alternative to Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alternative to Antibiotics Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Alternative to Antibiotics Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Alternative to Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Alternative to Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Alternative to Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Alternative to Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Alternative to Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Alternative to Antibiotics Market by Company

DSM

BioGaia

Bioriginal

Biosearch Life

China-Biotics

Chr. Hansen

Danone

DuPont(Danisco)

Ganeden

Glory Biotech

Greentech

Lallemand

Morinaga Milk Industry

Novozymes

Probi

Sabinsa

Synbiotech

UAS Laboratories

Valio

Yakult

Nestle

Alternative to Antibiotics Segment by Type

Antimicrobial Proteins

Bacteriophages

Probiotics

Other

Alternative to Antibiotics Segment by Application

Drugs

Food & Beverage

Dietary Supplements

Alternative to Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Alternative to Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Alternative to Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Alternative to Antibiotics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Alternative to Antibiotics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Alternative to Antibiotics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Alternative to Antibiotics Revenue of Manufacturers (2021-2026) Table 9. Global Alternative to Antibiotics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Alternative to Antibiotics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Alternative to Antibiotics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Alternative to Antibiotics, Product Type & Application Table 14. Global Alternative to Antibiotics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Alternative to Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. DSM Company Information Table 19. DSM Business Overview Table 20. DSM Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. DSM Alternative to Antibiotics Product Portfolio Table 22. DSM Recent Developments Table 23. BioGaia Company Information Table 24. BioGaia Business Overview Table 25. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. BioGaia Alternative to Antibiotics Product Portfolio Table 27. BioGaia Recent Developments Table 28. Bioriginal Company Information Table 29. Bioriginal Business Overview Table 30. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bioriginal Alternative to Antibiotics Product Portfolio Table 32. Bioriginal Recent Developments Table 33. Biosearch Life Company Information Table 34. Biosearch Life Business Overview Table 35. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Biosearch Life Alternative to Antibiotics Product Portfolio Table 37. Biosearch Life Recent Developments Table 38. China-Biotics Company Information Table 39. China-Biotics Business Overview Table 40. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. China-Biotics Alternative to Antibiotics Product Portfolio Table 42. China-Biotics Recent Developments Table 43. Chr. Hansen Company Information Table 44. Chr. Hansen Business Overview Table 45. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Chr. Hansen Alternative to Antibiotics Product Portfolio Table 47. Chr. Hansen Recent Developments Table 48. Danone Company Information Table 49. Danone Business Overview Table 50. Danone Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Danone Alternative to Antibiotics Product Portfolio Table 52. Danone Recent Developments Table 53. DuPont(Danisco) Company Information Table 54. DuPont(Danisco) Business Overview Table 55. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. DuPont(Danisco) Alternative to Antibiotics Product Portfolio Table 57. DuPont(Danisco) Recent Developments Table 58. Ganeden Company Information Table 59. Ganeden Business Overview Table 60. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Ganeden Alternative to Antibiotics Product Portfolio Table 62. Ganeden Recent Developments Table 63. Glory Biotech Company Information Table 64. Glory Biotech Business Overview Table 65. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Glory Biotech Alternative to Antibiotics Product Portfolio Table 67. Glory Biotech Recent Developments Table 68. Greentech Company Information Table 69. Greentech Business Overview Table 70. Greentech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Greentech Alternative to Antibiotics Product Portfolio Table 72. Greentech Recent Developments Table 73. Lallemand Company Information Table 74. Lallemand Business Overview Table 75. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Lallemand Alternative to Antibiotics Product Portfolio Table 77. Lallemand Recent Developments Table 78. Morinaga Milk Industry Company Information Table 79. Morinaga Milk Industry Business Overview Table 80. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Morinaga Milk Industry Alternative to Antibiotics Product Portfolio Table 82. Morinaga Milk Industry Recent Developments Table 83. Novozymes Company Information Table 84. Novozymes Business Overview Table 85. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novozymes Alternative to Antibiotics Product Portfolio Table 87. Novozymes Recent Developments Table 88. Probi Company Information Table 89. Probi Business Overview Table 90. Probi Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Probi Alternative to Antibiotics Product Portfolio Table 92. Probi Recent Developments Table 93. Sabinsa Company Information Table 94. Sabinsa Business Overview Table 95. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sabinsa Alternative to Antibiotics Product Portfolio Table 97. Sabinsa Recent Developments Table 98. Synbiotech Company Information Table 99. Synbiotech Business Overview Table 100. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Synbiotech Alternative to Antibiotics Product Portfolio Table 102. Synbiotech Recent Developments Table 103. UAS Laboratories Company Information Table 104. UAS Laboratories Business Overview Table 105. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. UAS Laboratories Alternative to Antibiotics Product Portfolio Table 107. UAS Laboratories Recent Developments Table 108. Valio Company Information Table 109. Valio Business Overview Table 110. Valio Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Valio Alternative to Antibiotics Product Portfolio Table 112. Valio Recent Developments Table 113. Yakult Company Information Table 114. Yakult Business Overview Table 115. Yakult Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Yakult Alternative to Antibiotics Product Portfolio Table 117. Yakult Recent Developments Table 118. Nestle Company Information Table 119. Nestle Business Overview Table 120. Nestle Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Nestle Alternative to Antibiotics Product Portfolio Table 122. Nestle Recent Developments Table 123. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Alternative to Antibiotics Sales by Region (2021-2026) & (K Units) Table 125. Global Alternative to Antibiotics Sales Market Share by Region (2021-2026) Table 126. Global Alternative to Antibiotics Sales by Region (2027-2032) & (K Units) Table 127. Global Alternative to Antibiotics Sales Market Share by Region (2027-2032) Table 128. Global Alternative to Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Alternative to Antibiotics Revenue Market Share by Region (2021-2026) Table 130. Global Alternative to Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Alternative to Antibiotics Revenue Market Share by Region (2027-2032) Table 132. North America Alternative to Antibiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 134. North America Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 135. North America Alternative to Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Alternative to Antibiotics Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Alternative to Antibiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 139. Europe Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 140. Europe Alternative to Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Alternative to Antibiotics Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Alternative to Antibiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Alternative to Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Alternative to Antibiotics Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Alternative to Antibiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 149. South America Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 150. South America Alternative to Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Alternative to Antibiotics Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Alternative to Antibiotics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Alternative to Antibiotics Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Alternative to Antibiotics Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Alternative to Antibiotics Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Alternative to Antibiotics Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Alternative to Antibiotics Sales by Type (2021-2026) & (K Units) Table 158. Global Alternative to Antibiotics Sales by Type (2027-2032) & (K Units) Table 159. Global Alternative to Antibiotics Sales Market Share by Type (2021-2026) Table 160. Global Alternative to Antibiotics Sales Market Share by Type (2027-2032) Table 161. Global Alternative to Antibiotics Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Alternative to Antibiotics Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Alternative to Antibiotics Revenue Market Share by Type (2021-2026) Table 164. Global Alternative to Antibiotics Revenue Market Share by Type (2027-2032) Table 165. Global Alternative to Antibiotics Price by Type (2021-2026) & (US$/Unit) Table 166. Global Alternative to Antibiotics Price by Type (2027-2032) & (US$/Unit) Table 167. Global Alternative to Antibiotics Sales by Application (2021-2026) & (K Units) Table 168. Global Alternative to Antibiotics Sales by Application (2027-2032) & (K Units) Table 169. Global Alternative to Antibiotics Sales Market Share by Application (2021-2026) Table 170. Global Alternative to Antibiotics Sales Market Share by Application (2027-2032) Table 171. Global Alternative to Antibiotics Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Alternative to Antibiotics Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Alternative to Antibiotics Revenue Market Share by Application (2021-2026) Table 174. Global Alternative to Antibiotics Revenue Market Share by Application (2027-2032) Table 175. Global Alternative to Antibiotics Price by Application (2021-2026) & (US$/Unit) Table 176. Global Alternative to Antibiotics Price by Application (2027-2032) & (US$/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Alternative to Antibiotics Distributors List Table 180. Alternative to Antibiotics Customers List Table 181. Alternative to Antibiotics Industry Trends Table 182. Alternative to Antibiotics Industry Drivers Table 183. Alternative to Antibiotics Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Alternative to Antibiotics Product Image Figure 5. Global Alternative to Antibiotics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Alternative to Antibiotics Market Size (2021-2032) & (US$ Million) Figure 7. Global Alternative to Antibiotics Sales (2021-2032) & (K Units) Figure 8. Global Alternative to Antibiotics Average Price (US$/Unit) & (2021-2032) Figure 9. Antimicrobial Proteins Product Image Figure 10. Bacteriophages Product Image Figure 11. Probiotics Product Image Figure 12. Other Product Image Figure 13. Drugs Product Image Figure 14. Food & Beverage Product Image Figure 15. Dietary Supplements Product Image Figure 16. Global Alternative to Antibiotics Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Alternative to Antibiotics Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Alternative to Antibiotics Sales by Region in 2025 Figure 22. Global Alternative to Antibiotics Revenue by Region in 2025 Figure 23. North America Alternative to Antibiotics Market Size by Country in 2025 Figure 24. North America Alternative to Antibiotics Sales Market Share by Country (2021-2032) Figure 25. North America Alternative to Antibiotics Revenue Market Share by Country (2021-2032) Figure 26. United States Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Alternative to Antibiotics Market Size by Country in 2025 Figure 29. Europe Alternative to Antibiotics Sales Market Share by Country (2021-2032) Figure 30. Europe Alternative to Antibiotics Revenue Market Share by Country (2021-2032) Figure 31. Germany Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Alternative to Antibiotics Market Size by Country in 2025 Figure 37. Asia Pacific Alternative to Antibiotics Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Alternative to Antibiotics Revenue Market Share by Country (2021-2032) Figure 39. China Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Alternative to Antibiotics Market Size by Country in 2025 Figure 48. South America Alternative to Antibiotics Sales Market Share by Country (2021-2032) Figure 49. South America Alternative to Antibiotics Revenue Market Share by Country (2021-2032) Figure 50. Mexico Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Alternative to Antibiotics Market Size by Country in 2025 Figure 54. Middle East and Africa Alternative to Antibiotics Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Alternative to Antibiotics Revenue Market Share by Country (2021-2032) Figure 56. Turkey Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Alternative to Antibiotics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Alternative to Antibiotics Sales Market Share by Type (2021-2032) Figure 60. Global Alternative to Antibiotics Revenue Market Share by Type (2021-2032) Figure 61. Global Alternative to Antibiotics Price (US$/Unit) by Type (2021-2032) Figure 62. Global Alternative to Antibiotics Sales Market Share by Application (2021-2032) Figure 63. Global Alternative to Antibiotics Revenue Market Share by Application (2021-2032) Figure 64. Global Alternative to Antibiotics Price (US$/Unit) by Application (2021-2032) Figure 65. Alternative to Antibiotics Value Chain Figure 66. Alternative to Antibiotics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Alternative to Antibiotics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Antimicrobial Proteins
  • Bacteriophages
  • Probiotics
  • Other
Applications
  • Drugs
  • Food & Beverage
  • Dietary Supplements
Companies covered
  • DSM
  • BioGaia
  • Bioriginal
  • Biosearch Life
  • China-Biotics
  • Chr. Hansen
  • Danone
  • DuPont(Danisco)
  • Ganeden
  • Glory Biotech
  • Greentech
  • Lallemand
  • Morinaga Milk Industry
  • Novozymes
  • Probi
  • Sabinsa
  • Synbiotech
  • UAS Laboratories
  • Valio
  • Yakult
  • Nestle

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Alternative to Antibiotics Market Size (2021-2032)
  4. 2.2.2 Global Alternative to Antibiotics Sales (2021-2032)
  5. 2.2.3 Global Alternative to Antibiotics Market Average Price (2021-2032)
  6. 2.3 Alternative to Antibiotics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Antimicrobial Proteins
  9. 2.3.3 Bacteriophages
  10. 2.3.4 Probiotics
  11. 2.3.5 Other
  12. 2.4 Alternative to Antibiotics by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Drugs
  15. 2.4.3 Food & Beverage
  16. 2.4.4 Dietary Supplements
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Alternative to Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Alternative to Antibiotics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Alternative to Antibiotics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Alternative to Antibiotics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Alternative to Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Alternative to Antibiotics, Product Type & Application
  8. 3.8 Global Manufacturers of Alternative to Antibiotics, Established Date
  9. 3.9 Global Alternative to Antibiotics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 DSM
  2. 4.1.1 DSM Company Information
  3. 4.1.2 DSM Business Overview
  4. 4.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 DSM Alternative to Antibiotics Product Portfolio
  6. 4.1.5 DSM Recent Developments
  7. 4.2 BioGaia
  8. 4.2.1 BioGaia Company Information
  9. 4.2.2 BioGaia Business Overview
  10. 4.2.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 BioGaia Alternative to Antibiotics Product Portfolio
  12. 4.2.5 BioGaia Recent Developments
  13. 4.3 Bioriginal
  14. 4.3.1 Bioriginal Company Information
  15. 4.3.2 Bioriginal Business Overview
  16. 4.3.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
  18. 4.3.5 Bioriginal Recent Developments
  19. 4.4 Biosearch Life
  20. 4.4.1 Biosearch Life Company Information
  21. 4.4.2 Biosearch Life Business Overview
  22. 4.4.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
  24. 4.4.5 Biosearch Life Recent Developments
  25. 4.5 China-Biotics
  26. 4.5.1 China-Biotics Company Information
  27. 4.5.2 China-Biotics Business Overview
  28. 4.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
  30. 4.5.5 China-Biotics Recent Developments
  31. 4.6 Chr. Hansen
  32. 4.6.1 Chr. Hansen Company Information
  33. 4.6.2 Chr. Hansen Business Overview
  34. 4.6.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
  36. 4.6.5 Chr. Hansen Recent Developments
  37. 4.7 Danone
  38. 4.7.1 Danone Company Information
  39. 4.7.2 Danone Business Overview
  40. 4.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Danone Alternative to Antibiotics Product Portfolio
  42. 4.7.5 Danone Recent Developments
  43. 4.8 DuPont(Danisco)
  44. 4.8.1 DuPont(Danisco) Company Information
  45. 4.8.2 DuPont(Danisco) Business Overview
  46. 4.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
  48. 4.8.5 DuPont(Danisco) Recent Developments
  49. 4.9 Ganeden
  50. 4.9.1 Ganeden Company Information
  51. 4.9.2 Ganeden Business Overview
  52. 4.9.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Ganeden Alternative to Antibiotics Product Portfolio
  54. 4.9.5 Ganeden Recent Developments
  55. 4.10 Glory Biotech
  56. 4.10.1 Glory Biotech Company Information
  57. 4.10.2 Glory Biotech Business Overview
  58. 4.10.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
  60. 4.10.5 Glory Biotech Recent Developments
  61. 4.11 Greentech
  62. 4.11.1 Greentech Company Information
  63. 4.11.2 Greentech Business Overview
  64. 4.11.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Greentech Alternative to Antibiotics Product Portfolio
  66. 4.11.5 Greentech Recent Developments
  67. 4.12 Lallemand
  68. 4.12.1 Lallemand Company Information
  69. 4.12.2 Lallemand Business Overview
  70. 4.12.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Lallemand Alternative to Antibiotics Product Portfolio
  72. 4.12.5 Lallemand Recent Developments
  73. 4.13 Morinaga Milk Industry
  74. 4.13.1 Morinaga Milk Industry Company Information
  75. 4.13.2 Morinaga Milk Industry Business Overview
  76. 4.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
  78. 4.13.5 Morinaga Milk Industry Recent Developments
  79. 4.14 Novozymes
  80. 4.14.1 Novozymes Company Information
  81. 4.14.2 Novozymes Business Overview
  82. 4.14.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Novozymes Alternative to Antibiotics Product Portfolio
  84. 4.14.5 Novozymes Recent Developments
  85. 4.15 Probi
  86. 4.15.1 Probi Company Information
  87. 4.15.2 Probi Business Overview
  88. 4.15.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Probi Alternative to Antibiotics Product Portfolio
  90. 4.15.5 Probi Recent Developments
  91. 4.16 Sabinsa
  92. 4.16.1 Sabinsa Company Information
  93. 4.16.2 Sabinsa Business Overview
  94. 4.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
  96. 4.16.5 Sabinsa Recent Developments
  97. 4.17 Synbiotech
  98. 4.17.1 Synbiotech Company Information
  99. 4.17.2 Synbiotech Business Overview
  100. 4.17.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
  102. 4.17.5 Synbiotech Recent Developments
  103. 4.18 UAS Laboratories
  104. 4.18.1 UAS Laboratories Company Information
  105. 4.18.2 UAS Laboratories Business Overview
  106. 4.18.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
  108. 4.18.5 UAS Laboratories Recent Developments
  109. 4.19 Valio
  110. 4.19.1 Valio Company Information
  111. 4.19.2 Valio Business Overview
  112. 4.19.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Valio Alternative to Antibiotics Product Portfolio
  114. 4.19.5 Valio Recent Developments
  115. 4.20 Yakult
  116. 4.20.1 Yakult Company Information
  117. 4.20.2 Yakult Business Overview
  118. 4.20.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Yakult Alternative to Antibiotics Product Portfolio
  120. 4.20.5 Yakult Recent Developments
  121. 4.21 Nestle
  122. 4.21.1 Nestle Company Information
  123. 4.21.2 Nestle Business Overview
  124. 4.21.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Nestle Alternative to Antibiotics Product Portfolio
  126. 4.21.5 Nestle Recent Developments
5 Global Alternative to Antibiotics Market Scenario by Region
  1. 5.1 Global Alternative to Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Alternative to Antibiotics Sales by Region: 2021-2032
  3. 5.2.1 Global Alternative to Antibiotics Sales by Region: 2021-2026
  4. 5.2.2 Global Alternative to Antibiotics Sales by Region: 2027-2032
  5. 5.3 Global Alternative to Antibiotics Revenue by Region: 2021-2032
  6. 5.3.1 Global Alternative to Antibiotics Revenue by Region: 2021-2026
  7. 5.3.2 Global Alternative to Antibiotics Revenue by Region: 2027-2032
  8. 5.4 North America Alternative to Antibiotics Market Facts & Figures by Country
  9. 5.4.1 North America Alternative to Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Alternative to Antibiotics Sales by Country (2021-2032)
  11. 5.4.3 North America Alternative to Antibiotics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Alternative to Antibiotics Market Facts & Figures by Country
  15. 5.5.1 Europe Alternative to Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Alternative to Antibiotics Sales by Country (2021-2032)
  17. 5.5.3 Europe Alternative to Antibiotics Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Alternative to Antibiotics Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Alternative to Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Alternative to Antibiotics Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Alternative to Antibiotics Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Alternative to Antibiotics Market Facts & Figures by Country
  35. 5.7.1 South America Alternative to Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Alternative to Antibiotics Sales by Country (2021-2032)
  37. 5.7.3 South America Alternative to Antibiotics Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Alternative to Antibiotics Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Alternative to Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Alternative to Antibiotics Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Alternative to Antibiotics Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Alternative to Antibiotics Sales by Type (2021-2032)
  2. 6.1.1 Global Alternative to Antibiotics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Alternative to Antibiotics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Alternative to Antibiotics Revenue by Type (2021-2032)
  5. 6.2.1 Global Alternative to Antibiotics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Alternative to Antibiotics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Alternative to Antibiotics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Alternative to Antibiotics Sales by Application (2021-2032)
  2. 7.1.1 Global Alternative to Antibiotics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Alternative to Antibiotics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Alternative to Antibiotics Revenue by Application (2021-2032)
  5. 7.2.1 Global Alternative to Antibiotics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Alternative to Antibiotics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Alternative to Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Alternative to Antibiotics Value Chain Analysis
  2. 8.1.1 Alternative to Antibiotics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Alternative to Antibiotics Production Mode & Process
  5. 8.2 Alternative to Antibiotics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Alternative to Antibiotics Distributors
  8. 8.2.3 Alternative to Antibiotics Customers
9 Global Alternative to Antibiotics Analyzing Market Dynamics
  1. 9.1 Alternative to Antibiotics Industry Trends
  2. 9.2 Alternative to Antibiotics Industry Drivers
  3. 9.3 Alternative to Antibiotics Industry Opportunities and Challenges
  4. 9.4 Alternative to Antibiotics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst